Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects

计划入组 24 人 · 首次发布于 2011 年 7 月 29 日

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects

计划入组 56 人 · 首次发布于 2011 年 2 月 17 日

A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers

计划入组 80 人 · 首次发布于 2012 年 2 月 23 日

ONO-RS-531

ONO-7161

ONO-1600586

Ono Pharma USA, Inc.

United States

Ono Pharma UK Ltd.

United Kingdom

Ono Pharmaceutical Co., Ltd.

Japan

ONO Pharmaceutical Completes Two Key Oncology Studies as Pipeline Advances

FDA Approves Ono Pharmaceutical's Novel Therapy for TGCT, Expanding Treatment Options

Ono Pharmaceutical Partners with Phylo to Embed Agentic AI Across Drug Discovery